An observational study in Infertile Women Undergoing IVF or ICSI, sponsored by LG Chem. Completed at 1 site in Korea, Republic of. Open to female participants aged 19 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-08-07.
Sponsored by LG Chem · Observational
To confirm the predictors based on patient specific characteristics and ovarian response and develop dosing chart when Follitrope™ PFS is administered to infertility women patients.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 534 is above the median of 200 across 714 observational studies indexed under Infertility.
Browse Infertility studies →LG Chem is the lead sponsor of 70 studies on the registry; 8 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 1 (8%) have results posted.
Counted across the registry records on this site, refreshed daily.
Infertile women undergoing In vitro fertilization(IVF) or Intracytoplasmic sperm injection (ICSI) for controlled ovarian stimulation
Exclusion Criteria:
GnRH agonist protocol \& GnRH antagonist protocol
No. of oocytes retrieved No. of oocytes retrieved Number of oocyte retrieved
Number of oocyte identified by ovum pick up (OPU) after overovulation
Time frame: after OPU, normally 2 weeks
Oocyte maturity quality
Metaphase II oocytes (%, ICSI only)
Time frame: after OPU, normally 2 weeks
Total dose (IU) of Follitrope™ PFS administered
Time frame: 2 weeks
Total duration (days) of Follitrope™ PFS administered
Time frame: 2 weeks
E2 concentration on hCG day
Time frame: normally 10 days
P4 concentration on hCG day
Time frame: normally 10 days
Fertilization rate
Time frame: 1~2 days after OPU
Number of embryo transferred
Time frame: 3~5 days after OPU
Implantation rate
Time frame: 24 days after OPU
Biochemical pregnancy rate
Time frame: 10 days after OPU
clinical pregnancy rate
Time frame: 24 days after OPU
pregnancy rate
Time frame: up to 10 weeks after OPU
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
LG Chem